Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 114, Issue 4, Pages 522-530Publisher
WILEY
DOI: 10.1002/ijc.20748
Keywords
beta-catenin; Lef/Tcf; fibronectin; type I collagen; ECM
Categories
Funding
- NIAMS NIH HHS [AR47347] Funding Source: Medline
- NIDDK NIH HHS [DK60588] Funding Source: Medline
Ask authors/readers for more resources
We have demonstrated recently that PTHrP is upregulated in pancreatic adenocarcinoma and that the ECM exerts regulatory control, at least in part, over PTHrP expression. In our present study, we examined the potential signaling interactions between these 2 pathways. Our results demonstrate that, under serum-free conditions, adhesion of FG pancreatic adenocarcinoma cells on Fn is mediated by the alpha(5)beta(1) integrin, whereas adhesion to Type I collagen is mediated by the alpha(2)beta(1), integrin. alpha(5)beta(1) integrin-mediated adhesion to Fn results in a phenotype that includes a reduction in cell proliferation, increased E-cadherin localization in cell-cell contacts, increased beta-catenin localization throughout the cell, inhibition of haptokinetic cell migration, and increased expression of PTHrP, IL-6 and IL-8 relative to alpha(2)beta(1) integrin-mediated adhesion on Type I collagen. A phosphoprotein immunoblotting screen of FG pancreatic cancer cells grown on either Fn or Type I collagen indicates that GSK3 and PKB/Akt are differentially phosphorylated on these 2 substrates. These results implicate GSK3 and PKB/Akt in the integrin-mediated regulation of PTHrP, IL-6 and IL-8 in pancreatic cancer. (C) 2004 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available